# Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora, Peristalsis, Immunity, and Anti-oxidative Capacity

> **NCT04046432** · NA · COMPLETED · sponsor: **SunWay Biotech Co., LTD.** · enrollment: 54 (actual)

## Conditions studied

- Gastrointestinal Microbiome

## Interventions

- **DIETARY_SUPPLEMENT:** Vigiis 101-LAB
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04046432
- **Lead sponsor:** SunWay Biotech Co., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-27
- **Primary completion:** 2017-12-22
- **Final completion:** 2018-03-20
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2019-08-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04046432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04046432, "Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora, Peristalsis, Immunity, and Anti-oxidative Capacity". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04046432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*